1 21 4

Shareholder Tools

Home Investor Relations

Investor Relations

  1. Chart
  2. Quote
Stock price graph
(NASDAQ: MGNX)
Price:
$34.57
Change:
- 0.05
Day High:
$35.67
Day Low:
$34.15
Volume:
165,200
4:00 PM ET on Feb 27, 2015

Delayed at least 20 minutes.
Provided by eSignal.

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. MacroGenics creates both differentiated molecules that are directed to novel cancer targets, as well as “bio-betters,” which are drugs designed to improve upon marketed medicines. The combination of MacroGenics’ technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.

Corporate Fact Sheet

Corporate Fact Sheet

PDF  Corporate Fact Sheet

View all »   RSSRecent Releases

Feb 24, 2015
MacroGenics Announces Date of Fourth Quarter and Full Year 2014 Financial Results Conference Call


Feb 5, 2015
MacroGenics to Present at the Leerink Global Healthcare Conference


View all »Events & Presentations

Mar 3, 2015 at 4:30 PM ET
MacroGenics, Inc. Fourth Quarter and Full Year 2014 Financial Results Conference Call